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Abstract: Photodamage is known to occur in skin with exposure to sunlight, specifically 
ultraviolet (UV) radiation. Such damage includes inflammation, oxidative stress, 
breakdown of the extracellular matrix, and development of cancer in the skin.  Sun 
exposure is considered to be one of the most important risk factors for both nonmelanoma 
and melanoma skin cancers. Many phytonutrients have shown promise as photoprotectants 
in clinical, animal and cell culture studies. In part, the actions of these phytonutrients are 
thought to be through their actions as antioxidants. In regard to skin health, phytonutrients 
of interest include vitamin E, certain flavonoids, and the carotenoids, β-carotene, lycopene 
and lutein. 
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1. Introduction 
Skin is the largest organ in the human body. It is exposed to environmental insult of which UV light 
is thought to be the most harmful [1].  UV exposure can cause oxidative stress, inflammation, 
erythema, breakdown of the extracellular matrix, wrinkling and skin cancer [2-4]. In fact, cumulative 
sun exposure is one of the most important risk factors for both nonmelanoma and melanoma   
skin cancers [5,6].  
Over 1 million skin cancers in the US are attributed to UV exposure per year, making it a 
significant public health concern [7]. The Healthy People 2010 goals include reducing sun exposure as 
part of the skin cancer reduction goals [8].  Skin cancer can be categorized as nonmelanoma and 
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melanoma. Nonmelanoma cancer includes basal cell carcinoma (BCC) and squamous cell carcinoma 
(SCC).  Nonmelanoma skin cancer has an estimated incidence of over 600,000 cases per year   
in the US.  Approximately 500,000 are BCCs and 100,000–150,000 are SCCs  [9].  Melanoma has   
an estimated incidence of between 11 and 14 per 100,000 cases per year in the US among   
white populations [10]. 
There are many ways to protect oneself from UV exposure including avoidance of the sun, wearing 
protective clothing (hats, long-sleeved shirts, treated fabrics, etc.), and topical sunscreen. However, the 
potential for dietary UV protection is a relatively recent concept. Compared to topical sunscreens 
which require reapplication and have localized  effects, dietary methods are thought to provide 
continual whole body protection. This promise has led to an explosion in nutrient containing products 
which are marketed for skin health improvement.  Common ingredients  of these products, both 
cosmetic and consumable, are antioxidant nutrients. While a variety of nutrients have been implicated 
in skin health [11,12], the purpose this review is to evaluate the evidence to date on the role of certain 
phytonutrients in skin health. Given the implication of oxidative stress being causative in 
photodamage, antioxidant nutrients are of interest in the prevention of such damage, the nutrients of 
interest in the study of photoprotection in skin include α-tocopherol, and certain flavonoids and   
β-carotene, lycopene, and lutein. 
2. UV Damage 
UV light is grouped as UVA (315–400 nm), UVB (280–315 nm) and UVC (220–280 nm), from 
lowest to highest energy. The Earth’s atmosphere filters out UVC light and of the remaining UV light 
to which we are exposed, 95% is UVA. The primary focus of UV research has been UVB light, but 
this is shifting toward UVA light. UVA is of higher wavelength which enables it to penetrate deeper 
into the skin [13]. UVB is mostly absorbed by the epidermal layer, but UVA affects the dermal layer 
as well.  UVA has demonstrated carcinogenicity in animal models  [14], emphasizing the need to 
understand and prevent the processes by which UVA exerts its biological effects. Clinical changes 
seen with photoaging, such as roughness, fine wrinkles, spotty hyperpigmentation, vasodilation, and 
loss of elasticity, are attributed primarily to UVA as well [15].  
UVA is thought to damage the skin primarily via generating reactive chemical species (ROS) upon 
absorption of photons by riboflavin, porphyrins and heme-containing proteins [14]. ROS, reactive 
nitrogen species (RNS)  as well as further enzymatic production of ROS  have been implicated. 
Reactive species can damage major biomolecules including DNA, proteins and lipids in various skin 
strata leading to cytotoxicity, mutations and alterations in cell signaling pathways. In cultured human 
fibroblasts from foreskin biopsies, UVA induced activity in p38 and c-Jun-N-terminal kinase (JNK) of 
the mitogen-activated protein kinase (MAPK) family, but not extracellular signal-regulated kinases 
(ERK)[16]. This activation was attributed to singlet oxygen (
1O2) because of subsequent inhibition by 
1O2 quenchers. This activation can lead to downstream activation of transcription factors that activate 
stress-inducible genes, specifically matrix metalloproteinase-1 (MMP-1). MMPs are responsible for 




Vitamin E refers to a family of eight nutrients of which α-tocopherol is the most abundant and 
biologically active form in the human body  (Figure  1).  The  α  form has 3 methyl groups on its 
chromanol ring and is recognized by the tocopherol transfer protein (TTP) which is responsible for its 
intracellular transport. This essential lipophilic nutrient is well known for its role as a chain-breaking 
antioxidant during lipid peroxidation and it protects polyunsaturated fatty acids in cell membranes 
from oxidation. Vitamin E also has the ability to affect signal transduction and gene expression [17]. 
Food sources include vegetables, vegetable oils, cereals and nuts [18]. Almonds are a particularly good 
source of α-tocopherol, containing approximately 26 mg per 100 g [19].  
Figure 1. Chemical structure of α-tocopherol (AT). 
 
α-Tocopherol concentrations in skin can be increased with oral or topical delivery [18] and are 
decreased with UV exposure [20]. Distribution among the layers of human skin has been determined 
(Table 1). Within human upper arm stratum corneum, a gradient of highest to lowest α-tocopherol 
concentration was found from lower to upper layers [21]. α-Tocopherol’s activity as an antioxidant, 
combined  with its presence in human skin, provide biologic plausibility for its role as a 
photoprotectant in skin.  
Table 1. Distribution of α-Tocopherol in human skin compartments. 
Skin Layer  Concentration  Reference 
Epidermis  31 ± 3.8 nmol /g tissue  Shindo et al. [20] 
Dermis  16.2 ± 1.1 nmol/g tissue  Shindo et al. [20] 
Stratum corneum  33 ± 4 nmol/g tissue  Thiele et al. [19] 
Sebum  76.5 ± 1.5 nmol/g sebum  Thiele et al. [21] 
3.1. Epidemiologic Studies 
In a review of epidemiologic literature, McNaughton et al. found evidence of a weak protective 
effect of vitamin E in nonmelanoma carcinoma (BCC and SCC)[22]. Of the 12 studies examined, two 
identified an inverse relationship between intake and BCC risk while one demonstrated a positive 
relationship. Six found no relationship between plasma or intake of vitamin E and BCC risk. Four 
studies found no association between vitamin E and SCC. More recently, two studies in an Australian 
population reported no association between serum α-tocopherol and nonmelanoma carcinoma but a 
positive association between dietary α-tocophero, including supplements, and BCC [23,24]. However, 
in these two studies a single baseline serum measurement or dietary assessment was compared to Nutrients 2010, 2  
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cancer incidence during an eight year period. These unexpected findings may reflect the possible 
inability of a single measure of vitamin E to accurately reflect vitamin E status and a change in eating 
habit cannot be ruled out over the 8 year period. Furthermore, these studies analyzed the association 
between cancer, which is a long-term outcome, and short-term markers of vitamin E intake or status 
such as dietary assessment and serum concentration.  Cancer may be closer related to skin 
concentrations which were not compared in any of these studies. 
There are no epidemiological studies assessing the relationship between topically applied   
α-tocopherol and skin cancer. 
3.2. Clinical Trials 
Clinical trials suggest that dietary vitamin E may act as a photoprotectant with the aid of other 
antioxidants and topical vitamin E may provide protection as well, although reports have not been 
entirely consistent. 
One study showed subjects treated with 400 IU/d α-tocopherol for eight weeks had reduced skin 
malondialdehyde (MDA) after UV exposure but this intervention provided  no protection from 
erythema, the reddening of the skin commonly referred to as sunburn [14]. Wernignaus et al. [25] 
showed no photoprotective effect after 6 months of daily dietary supplementation of α-tocopherol 
acetate (400 IU) in 12 subjects of skin types II-IV. Both clinical measure of minimal erythema dose 
(MED), the minimum dose of UV necessary to induce erythema in a subject, and histologic measure of 
sunburn cells were compared. No difference was seen in skin α-tocopherol concentrations between 
treatment and placebo groups. Plasma α-tocopherol concentrations increased by 65% in the treatment 
group and 18% in the placebo group, so there was no question of bioavailability. Although a very 
modest increase in MED was observed in the treatment group after 6 months, the sample size of this 
study may have been too small to observe significant changes. It is possible that α-tocopherol will 
provide the most benefit in subjects with a limited range in  skin types of increased risk for 
photodamage (very light to light). Additionally, repetitive UV doses lower than necessary to produce 
erythema are enough to cause local immunosuppression and skin carcinogenesis [15], suggesting that 
other markers of damage may be important such as DNA damage. 
Other  dietary  studies  have shown vitamin E  as a photoprotectant when  combined  with other 
antioxidants. Fuchs et al. [26] reported no protection when vitamin C (3 g) and α-tocopherol (2 g or 
3000 IU) were supplemented individually, but in combination these nutrients provided protection as 
assessed by increased MED after 50 days of daily supplementation. Eberlein-Konig et al. [27] also 
showed increased MED in subjects supplemented daily with a combination of vitamin C (2 g) and  
α-tocopherol  (1000 IU) after only 8 days.  A similar study showed increased MED in subjects 
supplemented daily with α-tocopherol (1200 IU) for 7 days, but when combined with vitamin C (2 g) a 
greater increase in MED was observed [28]. Placzek et al. [29] demonstrated a photoprotective effect 
after 3 months of daily dietary supplementation with vitamin C (1 g) and α-tocopherol (500 IU). 
Participants showed increased resistance to UVB-induced sunburn, as  assessed by MED, and 
protection from DNA damage. This study provides evidence of long-term photoprotection of lower 
doses than had been previously tested.  Nutrients 2010, 2  
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Clinical trials suggest that vitamin E applied topically also provides photoprotection. Chung et al. 
demonstrated topical application of 5% vitamin E  (24 hours prior to UV exposure)  inhibited  
UV-induced MMP-12 mRNA by 47% [30]. Other groups have reached opposing conclusions on the 
protection that vitamin E can provide from erythema. One group demonstrated reduced erythema when 
vitamin  E was applied prior to UV exposure but not after [31]. Another group found vitamin  E 
application after UV exposure protective, but not pretreatment [32].  
3.3. Animal Studies 
UVB irradiated mice fed α-tocopheryl acetate had less cancer incidence in a dose-dependent 
manner [33]. Dietary α-tocopherol esters are readily cleaved and free α-tocopherol is absorbed into the 
circulatory system. It should be noted that the doses used in this study were considered toxic given that 
more treated mice died compared to control mice.  A more recent experiment tested an oral 
combination of vitamin C, vitamin E, pycnogenol (a pine bark extract rich in polyphenols and 
procyanidins), and evening primrose oil in mice [34]. The nutrient cocktail treatment significantly 
inhibited UVB-induced wrinkling and many associated events, including expressions of MMPs, 
MAPK and activation of activator protein (AP)-1 transcriptional factor. While these results support a 
role for nutrient effects in photoprotection, specific effects of vitamin E could not be determined.  
Studies in mice treated topically with α-tocopherol provide strong evidence of photoprotection [18]. 
Mice treated topically with 25 mg α-tocopherol three times per week for three weeks before and 
during twelve weeks of UVB irradiation had significantly less incidence of skin cancer compared to 
untreated mice [35]. Four additional murine studies demonstrated photoprotection, assessed as skin 
tumor incidence, from topical α-tocopherol  treatment  [36-39].  A follow-up study using this same  
α-tocopherol treatment reduced induction of DNA damage by UVB [40]. Later studies by this group 
found acetate and succinate esterified forms of α-tocopherol  applied in the same manner did  not 
provide the same chemoprevention [41]. This difference may be due to the limited capacity to cleave 
acetate or succinate when applied topically. This limitation may compromise the antioxidant activity 
given that ester forms do not have a free hydroxyl group on the aromatic ring necessary for scavenging 
free radicals.  
An additional 15  animal  studies have consistently found topical pretreatment with vitamin E 
photoprotective using variety of outcome measures including erythema, lipid peroxidation, wrinkling 
and sunburn cell formation [42-56].  
3.4. In Vitro  
A human skin model has previously shown absorption of topical α-tocopherol  -glucoside,  
α-tocopherol and α-tocopherol acetate into epidermal and dermal compartments [57]. α-Tocopherol 
was not included in this study. Pig skin biopsies have been cultured showing pretreatment with topical 
α-tocopherol reduced UVB-induced cytotoxicity, apoptosis and lipid peroxidation [20]. In cultured 
mouse skin,  media  pretreatment of 9  µM  α-tocopherol-6-O-phosphate,  a water-soluble form of   
α-tocopherol,  reduced UVB-induced  apoptosis and lipid peroxidation  [58].  Media  pretreatment  of  
α-tocopherol  in human melanocytes prevented UVA-  and UVB-induced glutathione loss and 




Flavonoids are a family of over 5000 compounds found in plants. Flavonoid structure is based on a 
flavane nucleus, which contains two benzene rings separated by an oxygen containing pyrane ring. 
Individual  flavonoids  compounds have been reported to be radical scavengers, UVA absorbent, 
cytoprotective, anti-inflammatory anti-apoptotic, and to inhibit DNA damage and to affect   
cellular signaling pathways [60-62].  Collectively,  flavonoids  act  in vitro  as antioxidants and   
induce quinone reductase activity, a marker of chemopreventive activity [63]. Addition of almonds, a 
rich source of flavonoids,  to human diet has reduced biomarkers of oxidative stress [64].  
Predominant dietary flavonoids include isorhamnetin, catechin, kaempferol, epicatechin, quercetin and 
epigallocatechin-3-gallate (EGCG)(Figure 2)[65]. 
Figure 2. Chemical structure of predominant polyphenols.  
(+)-Catechin          (−)-Epicatechin 
     
Epigallocatechin-3-gallate        Quercetin 
     
Kaempferol          Isorhamnetin 
     
Absorption of flavonoids to human skin has not been tested. However, radioactivity was detected in 
the skin of mice fed 
3H-labeled EGCG, a closely related flavanol found in green tea [66]. From a 
single topical dose of EGCG, maximal concentrations of 1,366 and 411 ng/mL were measured in 
mouse epidermis and dermis, respectively [67].  Nutrients 2010, 2  
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4.1. Epidemiologic Studies 
Epidemiologic evidence suggests an association between flavonoid-rich foods and skin cancer 
incidence.  A case-control study in an Italian population found a negative correlation between 
cutaneous melanoma and daily tea drinking, high consumption of vegetables, particularly   
carrots, cruciferous and leafy vegetables, and fruits, especially citrus [68]. In the “Food Habits in  
Later Life” study, tea consumption was negatively correlated with actinic skin damage in   
Anglo-Celtic Australians [69].  
4.2. Clinical Trials 
The acute and long-term photoprotective effects of consumption of a flavanol-rich cocoa beverage 
was studied in  double-blind, placebo controlled clinical trials.  Epicatechin and its stereoisomer 
catechin are the major flavanols found in this beverage, contributing 61 and 20 mg/serving, 
respectively to a total of 329 mg cocoa flavanols. Two hours after a single dose of the flavanol-rich 
cocoa, dermal blood flow and oxygen saturation of hemoglobin significantly increased by 1.7- and  
1.8-fold, respectively [70].  Long-term, daily ingestion of the same flavanol-rich cocoa beverage 
decreased UV-induced erythema by 15% after only six weeks [71]. After twelve weeks, additional 
protection was evident as erythema was decreased by 25%. Blood flow of cutaneous and subcutaneous 
tissues, skin density and skin hydration were also increased while skin roughness and scaling were 
significantly decreased. None of these skin improvements was observed in the control group.  
Green tea contains the flavanols catechin and epicatechin. An eight week clinical trial evaluating 
the clinical and histological effects of combined topical and oral green tea supplementation (300 mg 
twice daily) found improvements in elastic tissue content [72]. However no significant differences in 
clinical grading of appearance were found. All subjects were asked to apply sunscreen daily which 
may have attenuated differences between groups.  
Immunosuppression was inhibited in participants after a single topical application of either green or 
white tea treatment (2.5 mg/cm
2) as evaluated by hypersensitivity to dinitrochlorobenzene [73]. The 
same topical treatments prevented DNA damage. Another study found a single topical dose of green 
tea treatment (1–4  mg/2.5  cm
2) protective of DNA damage,  in a dose-dependent manner [74].  
Long-term topical application of green tea treatment significantly reduced UV-induced p53 expression 
and apoptosis in keratinocytes, but not erythema [75]. 
Topical application of an extract of Culcitium reflexum H.B.K. leaves which contain isorhamnetin, 
quercetin and kaempferol significantly decreased erythema when applied after UVB irradiation [76].  
4.3. Animal Studies 
Investigations of foods rich in flavanoid nutrients demonstrate their efficacy as photoprotectants 
against UV carcinogenesis in animal models. Grape seed proanthocyanidins are polymers of flavanol 
monomers such as catechin and epicatechin [74]. In SKH-1 hairless mice, dietary supplementation 
with these compounds resulted in a dose-dependent reduction in photocarcinogenesis. Green tea as 
well as black tea consumption also resulted in significantly fewer UV-induced tumors in mice [77]. 
The administration of green tea polyphenols in drinking water or the topical application of EGCG, a Nutrients 2010, 2  
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major tea flavanol, also induced partial regression or inhibition of tumor growth of established skin 
papillomas in mice [78]. Gensler et al. also investigated EGCG in BALB/cAnNHsd mice. They found 
induction of skin tumors by UV irradiation was significantly reduced by topical but not by oral 
treatment of EGCG [79]. Other research has focused on acute photoprotection of EGCG. In Wistar 
rats, topical EGCG treatment for 30 minutes prior to UVA irradiation significantly decreased sunburn 
cell occurrence and dermo-epidermal activation compared to untreated rats [80]. The same protection 
was not observed with topical EGCG application 30 minutes after UVA exposure.  UVA-induced 
oxidative stress was significantly attenuated in Sprague-Dawley rats by intraperitoneal injections of 
quercetin prior to UV exposure [81].  Markers of oxidative stress included increased plasma 
malondialdehyde (a product of lipid peroxidation), decreased erythrocyte glutathione peroxidase and 
reductase activities, and decreased catalase  and superoxide sidmutase activities.  Topical quercetin 
treatment was found protective of UVB-induced oxidative stress in mouse skin as well [82].  
Positive photoprotective results from the above animal studies lead researchers to investigate the 
mechanism of protection. Dietary supplementation of green tea polyphenols in mice, during 8 weeks of 
UVB irradiation, inhibited UV-induced expression of MMPs, including MMP-2, -3, -7, and -9 [83]. 
All of these MMPs have been shown to be involved in the degradation of types-I and -III collagen 
fragments generated by collagenases and type IV collagen of the basement membrane.  
4.4. In Vitro Studies 
In human dermal fibroblasts, both quercetin and kaempferol inhibited MMP-1 (collagenase) activity 
and expression induced by UVA [34]. EGCG inhibited MMP-2 and -9 activity (gelatinases)[84]. Adult 
human skin fibroblasts and normal human epidermal keratinocytes,  cultured separately,  had 
significantly less DNA damage from UVA irradiation when treated with EGCG [85].  
Ex vivo cultured human skin experiments demonstrated pretreatment with topical green and white 
tea (2 mg/cm
2) provided protection from UV induced immunosuppression, measured by depletion of 
Langerhans cells [73]. Another ex vivo human skin experiment found topical cocoa polyphenol extract 
(containing catechin and epicatechin) improved skin structure after five days of application [86]. 
Glycosaminoglycans increased  as well as collagen I, II and IV expression, indicating improved 
elasticity and  skin tonus, respectively.  In  UVA exposed  artificial skin models, composed of 
differentiated epidermis on a dermal substitute, pretreatment with topical EGCG decreased expression 
of MMP-1 and -3  and activity of MMP-2 and -9  [87].  Tissue inhibitor of metalloproteinase-1  
(TIMP-1) expression increased simultaneously.  
5. Carotenoids 
Carotenoids are a family of compounds of over 600 fat-soluble plant pigments [88]. Fruits and 
vegetables are major sources of carotenoids [89]. Carotenoids are considered to be efficient scavenger 
of singlet molecular oxygen [90,91]. In fact, β-carotene (a major dietary carotenoid), at physiological 
concentrations, has been demonstrated to interact with UVA effects in keratinocytes by mechanisms 
that included singlet molecular oxygen quenching [92].  Other  dietary  major dietary carotenoids 
include lycopene, and lutein [89].  Nutrients 2010, 2  
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Carotenoids concentrations in human skin have been reported to range from 0.2 to 0.6 nmol/g wet 
weight  [93].  Carotenoid skin concentrations have been shown to vary by location on the   
body (forehead > palm > dorsal > inside arm = back of hand)[94-97]. Further, skin concentrations  
can be increased with supplementation [71]  and are lower in persons with oxidative stress   
(e.g., smokers)[94]. Similarly, plasma and skin carotenoids decrease with UV exposure [98,99]. Based 
on  the  presence  of carotenoids  in human skin and the known biologic activities of carotenoids, 
including quenching singlet oxygen species, carotenoids have been hypothesized to protect the skin 
from UV damage.  
5.1. Epidemiological Studies and Fruit & Vegetable Intakes 
Epidemiological studies have provided some evidence that fruit and vegetable intake may improve 
skin health and decrease the risk of skin cancer. However, in most cases, the specific effect of an 
individual carotenoid was not evaluated. Nonetheless, they provide evidence to support a role for 
carotenoids, and other phytonutrients, in skin health. 
In a cross-sectional study investigating the association between skin wrinkling and dietary intake, a 
significant negative association was found with eggs and green leafy vegetables [69]. Eggs are a highly 
bioavailable source or lutein [100] and green leafy vegetables are good sources of both β-carotene and 
lutein [89]. This relationship between carotenoids intake and skin wrinkling may be due to an ability to 
prevent extracellular matrix breakdown [101]. An association of green leafy vegetables with decreased 
risk of skin cancer has also been reported [102]. In this prospective study, a higher consumption of 
fruits and vegetables was related to decreased risk of SCC risk by 54%. This protective effect was 
mostly explained by the association with green leafy vegetables.  
In an observational study of an Italian population, high intake (at least 3 times per week) of dark 
green leafy vegetables was associated with decreased risk of cutaneous melanoma after adjustment for 
sex, age, education, hair color, skin phototypes, number of nevi, presence of freckles and sunburns in 
childhood [68]. In another observational study which looked at BCC and SCC, a decreased risk of 
SCC in persons with a history of skin cancer and high dietary intake of lutein and zeaxanthin was 
reported  [23].  Other studies show a mix of results including no association between serum 
lutein/zeaxanthin and BCC or SCC [24] and a positive association between serum lutein/zeaxanthin 
and risk of SCC in participants with a history of BCC [103].  Dietary  lutein  (combined with 
zeaxanthin) showed a slightly positive relationship with SCC and BCC incidence in women [104,105]. 
However, vitamins A, C, and E, folate and total carotenoids were also found to have a positive 
relationship. The mixed results of these studies could be due to limitations in dietary assessment or 
individual variability in the ability to accumulate certain phytonutrients in skin tissue. 
5.2. β-Carotene  
β-Carotene is in the carotene class of carotenoids (Figure 3). It is a strongly-colored red-orange 
pigment. As a carotene with beta-rings at both ends, it is the most common form of carotene. It is a 
precursor of vitamin A. Rich sources of β-carotene include yellow and orange fruits, such as mangoes 
and papayas, orange root vegetables such as carrots and yams and in green leafy vegetables such as 
spinach, kale, sweet potato leaves, and sweet gourd leaves [89]. β-Carotene inhibits free radical and Nutrients 2010, 2  
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singlet oxygen-induced lipid peroxidation in liposomes and the biologic system. It is a photoprotective 
agent and is thought to quench photochemical reactions in the epidermis involving singlet oxygen and 
oxygen radicals generated by UV exposure [106].  
Figure 3. Chemical structure of β-carotene. 
 
5.2.1. Epidemiologic Studies 
The epidemiologic studies that have evaluated a relationship between β-carotene and skin cancer 
risk have provided little support for a protective role of this carotenoid. No studies have found a 
relationship between plasma β-carotene and risk of BCC [107-114]. The few studies have examined 
SCC also found no relationships [110,112,114,115]. However, in a prospective study among 1001 
randomly selected adults, dietary intake of β-carotene in the second tertile was associated with 
increased risk of BCC, with no trend [116]. 
5.2.2. Clinical Trials 
The photoprotectiveness of β-carotene was first demonstrated with a study of healthy volunteers 
receiving 180 mg β-carotene/day for 10 weeks or a placebo [117]. Compared to the placebo group, 
threshold MED was significantly higher in the supplemented group, although there was no significant 
difference between the two groups in the degree of erythema. Similarly, in a placebo-controlled study 
involving 30 mg/day β-carotene for 10 weeks, there was a significantly decrease in the intensity of 
erythema induced by sunlight [118]. Lee et al. examined the effects of increasing does of β-carotene 
(30–90 mg/day for 24 weeks) on UV-induced erythema [119]. In a study evaluating the immune 
response to supplementation with either 30 mg/day β-carotene or a placebo was studied in 24 men  
(19–30 years)[120]. Subjects ingested the supplement with a low carotenoid diet for 70 days. From day 
28, the subjects were exposed to UV light 12 times over 16 days. No reductions in plasma carotenoid 
concentrations were observed in either group. Delayed-type hypersensitivity (DTH) skin responses 
decreased in the placebo group but were unchanged in the supplemented group. The investigators 
concluded that β-carotene  protected against photosuppression of the immune system and that BC 
supplementation may be beneficial in those with compromised immune function. 
Herraiz et al. conducted a similar study involving 32 elderly men (55–79 years) receiving either  
30 mg/day β-carotene or a placebo with a low carotenoid diet for 47 days [121]. Repeated exposure to 
UV light resulted in a decrease in DTH skin responses in the placebo group but not in the 
supplemented group and plasma β-carotene concentrations were unchanged. Higher plasma β-carotene 
concentrations were related to higher resistance to immunosuppression after exposure to UV light. 
The photoprotectiveness of β-carotene(24 mg/day) was compared to that of a carotenoid mixture of  
β-carotene, lycopene and lutein (8 mg/day  each) in a 12 week intervention trial [122].  Erythema 
intensity after irradiation with a solar light simulator was determined at baseline and at 6 and 12 weeks Nutrients 2010, 2  
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of supplementation. The intensity of erythema 24 hours after irradiation was significantly decreased to 
a similar level in both groups.  
A recent meta-analysis of controlled clinical trials reported an overall protective effect of   
β-carotene supplements against sunburn [123]. Although the studies to date suggest that high dose 
supplementation with β-carotene may be of benefit to skin health, there is a question of safety with 
these high intakes. Two intervention trials involving individuals at high risk for cancer, there was a 
significantly increased incidence of lung cancer in those that received the β-carotene  
supplement [124,125]. 
5.2.3. Animal Studies 
Minami et al. evaluated the role of lipid peroxidation products in MMP-9 activation and the effect 
of dietary β-carotene in MMP-9 activation. In this study, hairless mice were subjected to periodic 
UVA-irradiation for 8 weeks [126]. The amount of peroxidized cholesterol (primary product of lipid 
peroxidation in biomembranes) in the skin significantly increased by the UV exposure. The activity 
and protein level of MMP-9 were elevated, as well as the wrinkling and sagging formation. Adding  
β-carotene to the diet of the mice during the period of irradiation suppressed the activity and 
expression of MMP-9 along with the wrinkling and sagging formation. The amount of peroxidized 
cholesterol was also significantly lowered. These investigators concluded that dietary β-carotene 
prevents the expression of MMP-9, in part by inhibiting photodynamic action involved  in the 
formation of peroxidized cholesterol, the result of which was less wrinkling and sagging. 
5.2.4. In Vitro Studies 
β-Carotene, along with the carotenoids astaxanthin, and canthaxanthin, were evaluated for systemic 
photoprotection in human dermal fibroblasts [127]. Fibroblasts were exposed to moderate doses of 
UVA  which resulted in apoptosis and increased oxidative damage and expression of oxidative   
stress-response enzymes. When the carotenoids were delivered to fibroblasts 24 hours before exposure 
to exposure to UVA, astaxanthin exhibited a pronounced photoprotective effect and counteracted all of 
the measured UVA-induced alterations to a significant extent. β-Carotene only partially prevented the 
UVA-induced decline of  catalase and superoxide dismutase activities, but it increased  membrane 
damage and stimulated heme-ozygenase-1 expression. Furthermore,  β-carotene  dose-dependently 
induced caspase-3 activity following UVA  exposure.  However,  canthaxathin  had no effect on 
oxidative damage, except for heme-oxygenase-1 expression, which was increased. The data suggest 
that among the carotenoids tested, astaxanthin is the most protective towards photo-oxidative changes 
in cell culture. 
5.3. Lycopene  
Lycopene (Figure 4) is a carotene found in primarily in tomatoes but also in other red fruits and 
vegetables, such as red carrots, watermelons and papayas [89]. Unlike β-carotene, lycopene has no 
vitamin A activity  [128].  Lycopene is considered to be the most  the most efficient biological 
carotenoid singlet oxygen quencher [129]. A suggestion that lycopene may be protective in skin health Nutrients 2010, 2  
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comes from the work of Darvin et al. in which it was reported that there was a significant correlation 
between skin roughness and lycopene concentrations in the skin [130]. Topical application of lycopene 
contained in monoglyceride or triglyceride microemulsions was found to result in lycopene penetration 
in the stratum corneum (6-  and 3.6-fold, respectively) and in viable layers of porcine ear skin  
(from undetected to 172.6 and 103.1 ng/cm
2, respectively) compared to a control solution. 
Furthermore, the antioxidant activity of skin treated with lycopene was found to be 10-fold higher than 
untreated skin [131].  
Figure 4. Chemical structure of lycopene.  
 
5.3.1. Epidemiologic Studies 
Serum or plasma concentrations of lycopene were found to not be related with either BCC or  
SCC [110,113,114]. These results are contrary to observations in clinical trials (see below).  
5.3.2. Clinical Trials 
Intervention trials have been conducted to evaluate the effect of lycopene supplementation on 
erythema prevention [132,133].  The lycopene intervention was for 10–12 weeks and volunteers 
consumed one of five sources of lycopene: tomato paste (16 mg/day  lycopene); carrot juice   
(10 mg/day lycopene, 5.1 mg/day β-carotene; lycopene supplement (9.8 mg/day lycopene, 0.4 mg/day 
β-carotene); tomato extract (8.2 mg/day  lycopene, 0.4 mg β-carotene); or synthetic lycopene   
(10.2  mg/day  lycopene). In all studies serum lycopene significantly increased at study end. Skin 
carotenoids levels also increased with all interventions. However, only total carotenoids could be 
quantitated, as reflection spectroscopy was the method of assessment. With the exception of synthetic 
lycopene, all lycopene treatments were found to be effective in being photoprotective, as measured by 
erythema formation. Of note, is that that the synthetic lycopene was the only intervention to contain no 
other carotenoids. Additionally, the tomato-based interventions contain other constituents including the 
carotenoids phytofluene and phytoene. It is possible that these other carotenoid contribute to 
photoprotectiveness since they absorb light in the UV range.  
Darvin  et al.  evaluated the relationship between skin lycopene concentrations and skin   
roughness [130]. Lycopene was analyzed quantitatively on the forehead skin of 20 volunteers aged 
between 40 and 50 years. There was, no significant correlation between age and skin roughness   
but, a significant correlation was obtained between the skin roughness and the lycopene   
concentration (R = 0.843). 
These findings suggest that higher levels of lycopene in the skin effectively lead to lower levels of 
skin roughness, however, since other antioxidants were not evaluated, it if difficult to conclude that 
this relationship was specific to lycopene.  Nutrients 2010, 2  
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5.3.3. In Vitro Studies 
Lycopene has been shown to inhibit proliferation of several types of cancer cells through arrest of 
tumor cell-cycle progression, IGF-1 (insulin-like  growth factor 1) signaling transduction, and 
induction of apoptosis [134,135].  Wu  et al.  [136]  found that  lycopene inhibited PDGF-BB  
(platelet-derived  growth factor-BB)-induced signaling and cell migration  in human cultured skin 
fibroblasts through direct binding to PDGF-BB. Trapping of PDGF by lycopene also compromised 
melanoma-induced fibroblast migration and attenuated signaling transduction in fibroblasts simulated 
by melanoma-derived conditioned medium. These findings suggest that lycopene may interfere with 
tumor–stroma interactions. These investigators concluded that the trapping activity of lycopene on 
PDGF suggests that it may act as an inhibitor on stromal cells, tumor cells and their interactions, which 
may contribute to its anti-tumor activity. 
5.4. Lutein 
Lutein is a member of the xanthophyll class of carotenoids (Figure 5). Carotenoids are a family of 
more than 600 lipid-soluble compounds that are plant pigments. All carotenoids have a backbone 
composed of conjugated double bonds which is essential for their antioxidant activity. Xanthophylls, 
the most polar of carotenoids, are unique to this family because of their functional hydroxyl groups.  
Lutein is commonly found in fruits and vegetables. The richest source of lutein is leafy green 
vegetables but also can be found in significant amounts in broccoli, corn and peas [137,138]. Although 
levels are not high, lutein is also found in egg yolk, which is considered to be a highly bioavailable 
source of lutein [139]. There is no established Dietary Recommended Intake (DRI) for lutein, but 6 mg 
is associated with a reduced risk of cataracts and age-related macular degeneration [140-142]. Most 
Americans only get 1 to 2 mg/day [143-146]. 
Lutein has a well-established role in the eye health, acting as an antioxidant and absorbing blue 
light. Lutein also has an established presence in epidermal and dermal compartments of the skin and 
contributes to skin color [97].  
Figure 5. Chemical structure of lutein. 
 
5.4.1. Epidemiologic Studies 
Epidemiological studies have provided some evidence that the level of lutein intake may improve 
skin health and decrease the risk of skin cancer.  
In a cross-sectional study investigating the association between skin wrinkling and dietary intake, a 
significant negative association was found with eggs and green leafy vegetables [69]. This relationship 
between lutein intake and skin wrinkling may be due to lutein’s ability to prevent extracellular matrix 
breakdown [101]. An association of green leafy vegetables with decreased risk of skin cancer has also Nutrients 2010, 2  
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been reported [102]. In this prospective study, a higher consumption of fruits and vegetables was 
related to decreased risk of SCC risk by 54%, but this protective effect was mostly explained by the 
association with green leafy vegetables  
In an observational study of an Italian population, high intake (at least 3 times per week) of   
lutein-rich dark green leafy vegetables was associated with decreased risk of cutaneous melanoma after 
adjustment for sex, age, education, hair color, skin phototypes, number of nevi, presence of freckles 
and sunburns in childhood [68]. In another observational study which looked at BCC and SCC, a 
decreased risk of SCC in persons with a history of skin cancer and high dietary intake of lutein and 
zeaxanthin was reported [23]. Other studies show a mix of results including no association between 
dietary lutein-zeaxanthin and BCC or SCC [24] and a  positive association between serum   
lutein-zeaxanthin and risk of SCC in participants with a history of BCC [103].  Dietary lutein 
(combined with zeaxanthin) showed a slightly positive relationship with SCC and BCC incidence in 
women [104,105]. However, vitamins A, C, and E, folate and total carotenoids were also found to have 
a positive relationship. The mixed results of these studies could be due limitations in assessment of 
dietary lutein or individual variability in the ability to accumulate lutein in skin tissue, as has been 
noted for the macula [147-149]. 
5.4.2. Clinical Trials 
Results from clinical trials looking at photoprotection support a role for lutein in skin health. One of 
the earliest of these studies showed oral supplementation with 24 mg carotenoids/day (including   
8 mg/day each β-carotene, lutein and lycopene) improved UV-induced erythema in humans after only 
6 weeks of supplementation in a 12 week trial [71]. Others have shown an increase in skin hydration 
and superficial skin lipids with twice daily oral supplementation (45 mg vitamin C, 5 mg tocopherol,  
3 mg lutein  and 2.5 mg α-lipoic acid).  Also, skin lipid peroxides (a measure of oxidation) were   
decreased [150]. While these studies suggest a role for antioxidants in skin health, it is difficult to 
determine the individual contribution of lutein. 
Palombo et al. [150] provide strong evidence that increased lutein intake may improve skin health. 
This double-blind placebo controlled trial was designed to study the efficacy of oral supplementation 
(lutein 10 mg/day, zeaxanthin 0.6 mg/day) or topical application (lutein 100 ppm/day, zeaxanthin 
4 ppm/day) on five physiology parameters (surface lipids, hydration, photoprotective activity, skin 
elasticity, skin lipid peroxidation). This was a 12 week intervention. Oral or topical administration of 
these carotenoids significantly improved these measures, with oral administration providing better 
protection when measured by changes in lipid peroxidation and photoprotective activity in the skin 
following UV irradiation. However, the combined oral and topical administration provided the 
greatest protection. 
5.4.3. Animal Studies  
A study in hairless mice has shown protection from photocarcinogenesis (both number and   
size of tumors) with lutein  supplementation  [151].  In this study, mice  received either a 
lutein/zeaxanthin-supplemented diet or a standard nonsupplemented diet. Dorsal skin of female Skh-1 
hairless  mice  was exposed to UVB radiation in doses required for photoaging and for Nutrients 2010, 2  
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photocarcinogenesis. Clinical evaluations were performed weekly, and the animals were sacrificed  
24 h after the last UVB exposure. For photoaging experiments, skin fold thickness, suprapapillary 
plate thickness, mast cell counts and dermal desmosine content were evaluated.  For 
photocarcinogenesis, samples of tumors larger than 2 mm were analyzed for histological 
characterization, hyperproliferation index, tumor multiplicity, total tumor volume and tumor-free 
survival time. Results of the photoaging experiment found that skin fold thickness and number of 
infiltrating mast cells following UVB irradiation were significantly less in lutein/zeaxanthin-treated 
mice  when compared to irradiated animals on  the standard diet. In the  photocarcinogenesis 
experiment, tumor-free survival time increased, tumor multiplicity decreased and total tumor volume 
decreased in lutein/zeaxanthin-treated mice compared to control irradiated animals fed the standard 
diet. The results from this study suggest that dietary lutein/zeaxanthin supplementation protects the 
skin against UVB-induced photoaging and photocarcinogenesis. 
5.4.4. In Vitro 
Lutein protected rat kidney fibroblasts from UVA-induced oxidative stress, including decreases in 
the antioxidant enzymes, catalase  and  superoxide dismutase  [152].  Furthermore, in human lens 
epithelial cells, pretreatment with lutein  decreased UVB-induced lipid peroxidation and activation   
of p38 and JNK [153].  Lutein  significantly inhibited MMP-1 expression in dermal fibroblasts   
and melanoma cells [101]. Results from these in vitro studies lend mechanistic support to a lutein’s 
role in skin health. 
6. Conclusions and Summary 
Skin cancer is a significant public health concern. The skin is vulnerable to UV damage, which can 
lead to cancer. Possible mechanism by which this occurs include oxidative damage and inflammation. 
A diet rich in phytonutrients, including α-tocopherol, flavonoids, β-carotene, lycopene and lutein, may 
produce continual whole body protection from such damage. Epidemiological studies support a role 
for diets high in these food components and decreased risk of photoaging and cancer. However, the 
data are not entirely consistent. Stronger evidence comes from intervention studies which find 
supplementation  with  α-tocopherol,  flavonoids,  β-carotene, lycopene,  lutein  and various nutrient 
combinations  can protect  from  shorter-term markers of UV damage including lipid peroxidation, 
erythema, MMP expression, DNA damage, and apoptosis. Similar results are observed from topical 
treatments of these nutrients. Further investigation of optimal doses and mechanism of protection are 
needed to better target and prevent photodamage with dietary and/or topical treatments.  
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